0
     

Report Added
Report already added
North America Patient Simulator Market to 2025 - Regional Analysis and Forecasts by Product (Adult Patient Simulator, Infant Simulator and Childbirth Simulator), End User (Academic Institutes, Hospitals and Military Organizations), and Country

North America Patient Simulator Market to 2025 - Regional Analysis and Forecasts by Product (Adult Patient Simulator, Infant Simulator and Childbirth Simulator), End User (Academic Institutes, Hospitals and Military Organizations), and Country

The North America Patient simulator market is expected to reach US$ 1,047.0 Mn in 2025 from US$ 303.0 in 2017. The market is estimated to grow with a CAGR of 17.0% from 2018-2025.

The growth of the market is primarily attributed to the factors such as, increasing adoption of minimally invasive surgeries and growing high-tech innovation.

Patient simulators are combined with computer software, which replicates normal and abnormal bodily reactions to events, such as asthma attack and therapeutic interventions, which include a drug side effect. Simulated blood can be pumped into the veins through an intravenous (IV) tube. Patient simulators are life-like manikins that react physiologically as a normal human being. The stimulators are specifically designed with respiratory therapy, nursing, and emergency medical students in mind.

Advancement in the field of patient simulators has enhanced the market. Many industry players have come up with innovative types of simulators in the last few years. The advancement in the simulators has led to faster and easier treatment and recovery of patients. Besides, the investments from public and private investors are rising for the simulators. In order to improvise the technique, there have been various innovations as well as developments in the field. There have been numerous image enhancement innovations in recent years to enable better usage of simulators.

New technologies were developed to reduce the time of the surgeons and the patients. For instance, in January 2018, CAE Healthcare launched the CAE LucinaAR with Microsoft HoloLens, the world’s first augmented reality childbirth simulator with integrated mother-baby physiology. Thus, the innovative steps and technological advancements were undertaken by new entrants as well as established market players to improve the quality and efficacy of patient simulators is expected to favor the growth of the market in the years to come.

In 2017, the adult patient simulator segment held a largest market share of the patient simulator market, by product. the adult patient simulator segment is also expected to dominate its market share in 2025 The adult patient simulators are wireless, affordable and are built to withstand a wide variety of learning environments, they are preferred simulator for indoor/outdoor interdisciplinary scenarios requiring triage, treatment and transport. Thus the demand for the adult patient simulator segment is anticipated to grow at a considerable rate.

.

In 2017, the academic institutes held a largest market share of the patient simulator market, by end user. This segment is also expected to dominate the market in 2025. Moreover, the similar segment is expected to grow at the fastest growth rate during the forecast period, 2018 to 2025.

Some of the major primary and secondary sources for patient simulator included in the report are, Canadian Association of Geographers (CAG), Centers for Disease Control and Prevention (CDC), Pan American Health Organization, The U.S. Embassy in Mexico, through its Agency for International Development Organization for Economic Co-operation and Development (OECD) and others.

TABLE OF CONTENTS
1. Introduction
1.1 Scope Of The Study
1.2 The Insight Partners Research Report Guidance
2. North America Patient Simulator Market - Key Takeaways
3. North America Patient Simulator Market - Market Landscape
3.1 Overview
3.1.1 North America Patient Simulator Market - By Product
3.1.2 North America Patient Simulators Market - By End User
3.1.3 North America Patient Simulator Market - By Country
3.2 PEST Analysis
4. North America Patient Simulator Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Adoption of Minimally Invasive Surgeries
4.1.2 Growing High-tech Innovation
4.2 Key Market challenge
4.2.1 High Cost Associated With Patient Simulators
4.3 Key Market Opportunity
4.3.1 Rising Awareness on Simulation Education
4.4 Future Trend
4.4.1 Use of Virtual Reality and Augmented Reality in Patient Simulators
4.5 Impact analysis
5. Patient Simulator Market - North America Analysis
5.1 North America Patient Simulator Market Revenue Forecasts And Analysis
6. North America Patient Simulator Market Analysis - By Product
6.1 Overview
6.2 North America Patient Simulator Market By Product, 2017 & 2025 (%)
6.3 North America Patient Simulator Market Revenue and Forecasts To 2025, By Product (US$ Mn)
6.4 Adult Patient Simulators Market
6.4.1 Overview
6.4.2 North America Adult Patient Simulators Market Revenue and Forecast to 2025 (US$ Mn)
6.5 Infant Simulators Market
6.5.1 Overview
6.5.2 North America Infant Simulators Market Revenue and Forecast to 2025 (US$ Mn)
6.6 Childbirth Simulators Market
6.6.1 Overview
6.6.2 North America Childbirth Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
7. North America Patient Simulator Market Analysis - By End User
7.1 Overview
7.2 North America Patient Simulator Market, By End User, 2017 & 2025 (%)
7.3 North America Patient Simulator Market Revenue and Forecasts To 2025, By End User (US$ Mn)
7.4 Academic Institutes Market
7.4.1 Overview
7.4.2 North America Academic institutes Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 Hospitals Market
7.5.1 Overview
7.5.2 North America Hospitals Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 Military Organizations Market
7.6.1 Overview
7.6.2 North America Military Organizations Market Revenue and Forecasts to 2025 (US$ Mn)
8. North America Patient Simulator Market Revenue and Forecasts To 2025
8.1 Overview
8.2 North America Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
8.3 North America patient Simulators Market Revenue and Forecasts to 2025, By Product (US$ Mn)
8.4 North America Patient Simulators Market Revenue And Forecasts to 2025, By End user (US$ Mn)
8.5 North America Patient Simulators Market shaRe, By Country (2017 & 2025) (%)
8.6 US Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
8.6.1 US Patient Simulators Market Revenue And Forecasts to 2025 (US$ Mn)
8.6.2 US Patient Simulators Market Revenue and Forecasts to 2025, By Product (US$ Mn)
8.6.3 US Patient Simulators Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.7 Canada Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
8.7.1 Canada Patient Simulators Market Revenue And Forecasts to 2025 (US$ Mn)
8.7.2 Canada Patient Simulators Market Revenue and Forecasts to 2025, By Product (US$ Mn)
8.7.3 Canada Patient Simulators Market Revenue And Forecasts to 2025, By End User (US$ Mn)
8.8 Mexico Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
8.8.1 Mexico Patient Simulators Market Revenue And Forecasts To 2025 (US$ Mn)
8.8.2 Mexico Patient Simulators Market Revenue and Forecasts to 2025, By Product (US$ Mn)
8.8.3 Mexico Patient Simulators Market Revenue And Forecasts to 2025, By End User (US$ Mn)
9. North America Patient Simulator Market - Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Patient Simulators Market, 2016-2019
9.3 Inorganic Growth Strategies
9.3.1 Overview
9.4 Inorganic Growth Strategies in the Patient Simulators Market, 2016-2019
9.5 Agreements
9.5.1 Recent Agreements By Players in the Patient Simulators Market
9.6 Partnership
9.6.1 Recent Partnership By Players In The Patient Simulators Market
9.7 Acquisitions
9.7.1 Recent Acquisitions By Players in the Patient Simulators Market
9.8 Organic Growth strategies Developments
9.8.1 Overview
9.9 Organic Growth Strategies in the patient simulators Market, 2016-2019
9.10 Product Launch
9.10.1 Recent Product Launches By Players In The Patient Simulators Market
9.11 Product Approvals
9.11.1 Recent Product Approvals By Players In The Patient Simulators Market
10. Patient Simulators Market-Key Company Profiles
10.1 CAE
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Laerdal Medical
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 3D Systems, Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Gaumard Scientific
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Information
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Kyoto Kagaku Co., Ltd.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Simulab Corporation
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Information
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Simulaids
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Surgical Science
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Mentice AB
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product Portfolio
10.9.5 SWOT ANALYSIS
10.9.6 Key Developments
10.10 Limbs & Things LTD
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.4 Coverage
11.5 Secondary Research
11.6 Primary Research


LIST OF TABLES
Table 1. North America Patient Simulator Market Revenue and Forecasts To 2025, By Product (US$ Mn)
Table 2. North America Patient Simulator Materials Market Revenue and Forecasts To 2025, By End User (US$ Mn)
Table 3. North America Patient Simulator Market Revenue and Forecasts To 2025, By End User (US$ Mn)
Table 4. North America Patient Simulators Market Revenue And Forecasts to 2025, By Product (US$ Mn)
Table 5. North America Patient Simulators Market Revenue And Forecasts to 2025, By End user (US$ Mn)
Table 6. US Patient Simulators Market Revenue And Forecasts to 2025, By Product (US$ Mn)
Table 7. US Patient Simulators Market Revenue And Forecasts to 2025, By End User (US$ Mn)
Table 8. Canada Patient Simulators Market Revenue And Forecasts to 2025, By Product (US$ Mn)
Table 9. Canada Patient Simulators Market Revenue And Forecasts to 2025, By End user (US$ Mn)
Table 10. Mexico Patient Simulators Market Revenue And Forecasts to 2025, By Product (US$ Mn)
Table 11. Mexico Patient Simulators Market Revenue And Forecasts to 2025, By End user (US$ Mn)
Table 12. Recent Agreements By Players in the Patient Simulators Market, 2016-2019
Table 13. Recent Partnership in the Patient Simulators Market, 2016-2019
Table 14. Acquisitions in the Patient Simulators Market, 2016-2019
Table 15. Recent Product Launches in the Patient Simulators Market, 2016-2019
Table 16. Recent Product Approvals and Enhancements in the Patient Simulators Market, 2016-2019
Table 17. Glossary of Terms, Patient Simulators Market

LIST OF FIGURES
Figure 1. US Patient Simulator Market, Revenue (US$ Mn), By Country 2017 & 2025
Figure 2. North America Patient Simulator Market By Product, Market Share (%), 2017
Figure 3. North America Patient Simulator Market By End User, Market Share (%), 2017
Figure 4. Patient Simulator Market Segmentation
Figure 5. North America PEST Analysis
Figure 6. Patient Simulators MARKET impact analysis of driver and restraints
Figure 7. North America Patient Simulator Market - Revenue Forecasts And Analysis - 2017- 2025
Figure 8. North America Patient Simulator Market, By Product 2017 & 2025 (%)
Figure 9. North America Adult Patient Simulators Market Revenue and Forecasts To 2025 (US$ Mn)
Figure 10. North America Infant Simulators Market Revenue and Forecasts To 2025 (US$ Mn)
Figure 11. North America Childbirth simulators Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 12. North America Patient Simulator Market By End User, 2017 & 2025 (%)
Figure 13. North America Academic Institutes Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 14. North America Hospitals Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 15. North America Military Organizations Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 16. North America Patient Simulator Market Revenue Overview, By Country (2017) (US$ Mn)
Figure 17. North America Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 18. North America Patient Simulators Market Share, By Country (2017 & 2025) (%)
Figure 19. US Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 20. Canada Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 21. Mexico Patient Simulators Market Revenue and Forecasts to 2025 (US$ Mn)
Figure 22. Growth Strategies in the Patient Simulators Market, 2016-2019
Figure 23. Inorganic Developments in the Patient Simulators Market, 2016-2019
Figure 24. Organic Growth Strategies in the Patient Simulators Market, 2016-2019

Report Title: North America Patient Simulator Market to 2025 - Regional Analysis and Forecasts by Product (Adult Patient Simulator, Infant Simulator and Childbirth Simulator), End User (Academic Institutes, Hospitals and Military Organizations), and Country


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Bispecific Antibodies  Market & Clinical Pipeline Insight 2028

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Vietnam Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Venezuela Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Uruguay Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 United Arab Emirates Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening  Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline

2023-2027 Ukraine Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Analyzers and Reagents--Transfusion Market Emerging Opportunities, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts for 40 Immunohematology and NAT Assays through 2027, Latest Technologies and Instrumentation Pipeline